|
US5606040A
(en)
|
1987-10-30 |
1997-02-25 |
American Cyanamid Company |
Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyl-trithio group
|
|
US5773001A
(en)
|
1994-06-03 |
1998-06-30 |
American Cyanamid Company |
Conjugates of methyltrithio antitumor agents and intermediates for their synthesis
|
|
US5714586A
(en)
|
1995-06-07 |
1998-02-03 |
American Cyanamid Company |
Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
|
|
US5712374A
(en)
|
1995-06-07 |
1998-01-27 |
American Cyanamid Company |
Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
|
|
US5733001A
(en)
|
1996-11-19 |
1998-03-31 |
Roberts; Clifford D. |
Seat cover retainer apparatus and method of using same
|
|
AU2002348178A1
(en)
*
|
2002-11-06 |
2004-06-03 |
Wyeth |
Combination therapy for the treatment of acute leukemia and myelodysplastic syndrome
|
|
EP2211870A1
(en)
*
|
2007-11-01 |
2010-08-04 |
Celgene Corporation |
Cytidine analogs for treatment of myelodysplastic syndromes
|
|
EP3241902B1
(en)
|
2012-05-25 |
2018-02-28 |
The Regents of The University of California |
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
|
|
WO2014093694A1
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Crispr-cas nickase systems, methods and compositions for sequence manipulation in eukaryotes
|
|
EP3556858A3
(en)
|
2014-04-09 |
2020-01-22 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating cystic fibrosis
|
|
US10900034B2
(en)
|
2014-12-03 |
2021-01-26 |
Agilent Technologies, Inc. |
Guide RNA with chemical modifications
|
|
EP3280803B1
(en)
|
2015-04-06 |
2021-05-26 |
The Board of Trustees of the Leland Stanford Junior University |
Chemically modified guide rnas for crispr/cas-mediated gene regulation
|
|
JP7109784B2
(ja)
|
2015-10-23 |
2022-08-01 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
遺伝子編集のための進化したＣａｓ９蛋白質
|
|
WO2017177011A1
(en)
*
|
2016-04-06 |
2017-10-12 |
University Of Florida Research Foundataion, Inc. |
Biomarkers for anti-leukemic therapy
|
|
US10767175B2
(en)
|
2016-06-08 |
2020-09-08 |
Agilent Technologies, Inc. |
High specificity genome editing using chemically modified guide RNAs
|
|
AU2017388753A1
(en)
|
2016-12-30 |
2019-07-11 |
Editas Medicine, Inc. |
Synthetic guide molecules, compositions and methods relating thereto
|
|
SG11201907870VA
(en)
*
|
2017-02-28 |
2019-09-27 |
Vor Biopharma Inc |
Compositions and methods for inhibition of lineage specific proteins
|
|
JP2020510439A
(ja)
|
2017-03-10 |
2020-04-09 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
シトシンからグアニンへの塩基編集因子
|
|
CA3057192A1
(en)
|
2017-03-23 |
2018-09-27 |
President And Fellows Of Harvard College |
Nucleobase editors comprising nucleic acid programmable dna binding proteins
|
|
US11718659B2
(en)
*
|
2017-08-28 |
2023-08-08 |
The Trustees Of Columbia University In The City Of New York |
CD33 exon 2 deficient donor stem cells for use with CD33 targeting agents
|
|
MX2021008490A
(es)
*
|
2019-01-16 |
2021-09-28 |
Univ Columbia |
Composiciones y metodos para la inhibicion de antigenos con especificidad de linaje.
|